Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy
Clinical trial NCT02889523 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02889523
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2023-01-31
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.